Novel nanoparticle technology to identify healthcare-associated infections receives $1.5 million

(University of Toronto – Leslie Dan Faculty of Pharmacy) Healthcare-associated infections are the fourth leading cause of death in Canada, predicted to move up to second place by 2050. Scientists at the Leslie Dan Faculty of Pharmacy, University of Toronto received $1.5 million in funding from Genome Canada to develop a new nanoparticle sensor technology that will allow hospitals and long-term care facilities to rapidly detect and visually identify highly infectious pathogens including C. difficile, methicillin-resistant S aureus (MRSA), Norovirus and influenza.